665 related articles for article (PubMed ID: 34081097)
21. POEMS syndrome: diagnostic delay and successful treatment with lenalidomide, cyclophosphamide and prednisone followed by autologous peripheral stem cell transplantation.
Ordway S; Gilbert L; Wanko S
BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30054320
[TBL] [Abstract][Full Text] [Related]
22. POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2011 Jul; 86(7):591-601. PubMed ID: 21681783
[TBL] [Abstract][Full Text] [Related]
23. POEMS syndrome: the matter-of-fact approach.
Scarlato M; Previtali SC
Curr Opin Neurol; 2011 Oct; 24(5):491-6. PubMed ID: 21677582
[TBL] [Abstract][Full Text] [Related]
24. An update on the diagnosis and management of the polyneuropathy of POEMS syndrome.
Cerri F; Falzone YM; Riva N; Quattrini A
J Neurol; 2019 Jan; 266(1):258-267. PubMed ID: 30264176
[TBL] [Abstract][Full Text] [Related]
25. Treatment-responsive glycogen storage myopathy in a patient with POEMS syndrome: A new monoclonal gammopathy-associated myopathy.
Soontrapa P; Tracy JA; Gonsalves WI; Liewluck T
Eur J Neurol; 2023 Oct; 30(10):3404-3406. PubMed ID: 37522432
[TBL] [Abstract][Full Text] [Related]
26. [POEMS syndrome. An interdisciplinary clinical challenge].
Braun SA; Albrecht P; Methner A; Hanneken S
Hautarzt; 2011 Oct; 62(10):722-5. PubMed ID: 21915731
[TBL] [Abstract][Full Text] [Related]
27. POEMS syndrome: update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2015 Oct; 90(10):951-62. PubMed ID: 26331353
[TBL] [Abstract][Full Text] [Related]
28. POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2014 Feb; 89(2):214-23. PubMed ID: 24532337
[TBL] [Abstract][Full Text] [Related]
29. POEMS syndrome: update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2012 Aug; 87(8):804-14. PubMed ID: 22806697
[TBL] [Abstract][Full Text] [Related]
30. Lenalidomide and Dexamethasone for a Patient of POEMS Syndrome Presenting with Massive Ascites.
Ueda S; Yonemoto S; Oka K; Fujii N; Nakata K; Matsunaga H; Kataoka S; Iwama Y; Narahara H; Yasunaga Y; Inui Y; Kawata S
Case Rep Hematol; 2014; 2014():818946. PubMed ID: 24782932
[TBL] [Abstract][Full Text] [Related]
31. POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, and Skin Changes): A Case Report of a Rare Paraneoplastic Syndrome.
Sakhuja A; Shrestha DB; Mir WAY; Gaire S; Kassem M
Cureus; 2022 May; 14(5):e24980. PubMed ID: 35719778
[TBL] [Abstract][Full Text] [Related]
32. POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome Masquerading as Chronic Inflammatory Polyradiculoneuropathy: A Case Report.
Bayas A; Hammond T; Swerdloff MA
Cureus; 2022 Nov; 14(11):e31481. PubMed ID: 36523729
[TBL] [Abstract][Full Text] [Related]
33. Polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes (POEMS syndrome): a paraneoplastic syndrome.
Kumar S; Sharma S
Oxf Med Case Reports; 2015 Mar; 2015(3):237-40. PubMed ID: 26634133
[TBL] [Abstract][Full Text] [Related]
34. Update on the POEMS syndrome.
Kim YR
Blood Res; 2022 Apr; 57(S1):27-31. PubMed ID: 35483922
[TBL] [Abstract][Full Text] [Related]
35. POEMS syndrome.
Keddie S; Lunn MP
Curr Opin Neurol; 2018 Oct; 31(5):551-558. PubMed ID: 30138145
[TBL] [Abstract][Full Text] [Related]
36. POEMS syndrome: clinical update.
Brown R; Ginsberg L
J Neurol; 2019 Jan; 266(1):268-277. PubMed ID: 30498913
[TBL] [Abstract][Full Text] [Related]
37. Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome: impact of autologous hematopoietic stem cell transplantation.
Barete S; Mouawad R; Choquet S; Viala K; Leblond V; Musset L; Amoura Z; Khayat D; Francès C
Arch Dermatol; 2010 Jun; 146(6):615-23. PubMed ID: 20566924
[TBL] [Abstract][Full Text] [Related]
38. Unraveling the Neurological Complexity of Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, and Skin Changes Syndrome: A Report of a Challenging Case of a Young Woman and Cutting-Edge Advancements in the Field.
Furciniti G; Casalino G; Lo Russo FM; Bolli N; Meneri M; Comi GP; Corti SP; Velardo D
Diseases; 2023 Nov; 11(4):. PubMed ID: 37987277
[TBL] [Abstract][Full Text] [Related]
39. The Peripheral Neuropathies of POEMS Syndrome and Castleman Disease.
Mauermann ML
Hematol Oncol Clin North Am; 2018 Feb; 32(1):153-163. PubMed ID: 29157616
[TBL] [Abstract][Full Text] [Related]
40. Recent Advances in the Treatment and Supportive Care of POEMS Syndrome.
Bou Zerdan M; George TI; Bunting ST; Chaulagain CP
J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
